📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Additional file 1: of Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts (2019)

First Author: Alexander M

Attributed to: Stat2 is a therapeutic target in liver inflammation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.6084/m9.figshare.8150834

Publication URI: https://springernature.figshare.com/articles/Additional_file_1_of_Risks_and_clinical_predictors_of_cirrhosis_and_hepatocellular_carcinoma_diagnoses_in_adults_with_diagnosed_NAFLD_real-world_study_of_18_million_patients_in_four_European_cohorts/8150834

Type: Other